Literature DB >> 1369415

Transcriptional regulation by the nuclear receptor superfamily.

V C Yu1, A M Näär, M G Rosenfeld.   

Abstract

In the past year, additional experimental data have expanded our understanding of the molecular mechanisms that underlie nuclear receptor control of regulatory programs. It is increasingly clear that steroid members (e.g. glucocorticoid and estrogen) and non-steroid members (e.g. retinoic acid, thyroid hormone, and vitamin D) of the nuclear receptor superfamily may utilize distinct strategies in achieving their complex control of gene regulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1369415     DOI: 10.1016/0958-1669(92)90002-z

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  8 in total

1.  A 12(S)-hydroxyeicosatetraenoic acid receptor interacts with steroid receptor coactivator-1.

Authors:  Y Kurahashi; H Herbertsson; M Söderström; M G Rosenfeld; S Hammarström
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.

Authors:  N Jabrane-Ferrat; J D Fontes; J M Boss; B M Peterlin
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

3.  The vitamin D(3) receptor in the context of the nuclear receptor superfamily : The central role of the retinoid X receptor.

Authors:  C Carlberg
Journal:  Endocrine       Date:  1996-04       Impact factor: 3.633

4.  The high affinity ligand binding conformation of the nuclear 1,25-dihydroxyvitamin D3 receptor is functionally linked to the transactivation domain 2 (AF-2).

Authors:  S Nayeri; J P Kahlen; C Carlberg
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

5.  Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation.

Authors:  M Schräder; S Nayeri; J P Kahlen; K M Müller; C Carlberg
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

6.  Transferrin-PEG-PE modified dexamethasone conjugated cationic lipid carrier mediated gene delivery system for tumor-targeted transfection.

Authors:  Wei Wang; Fang Zhou; Linfu Ge; Ximin Liu; Fansheng Kong
Journal:  Int J Nanomedicine       Date:  2012-05-21

7.  PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.

Authors:  A Perez; P Kastner; S Sethi; Y Lutz; C Reibel; P Chambon
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

8.  RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo.

Authors:  S Nagpal; S Friant; H Nakshatri; P Chambon
Journal:  EMBO J       Date:  1993-06       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.